Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

PI3K plays a key role in cellular metabolism and cancer. Using a mass spectrometry-based metabolomics platform, we discovered that plasma concentrations of 26 metabolites, including amino acids, acylcarnitines, and phosphatidylcholines, were decreased in mice bearing PTEN-deficient tumors compared w...

ver descrição completa

Detalhes bibliográficos

Main Authors:	Ang, Joo Ern, Pandher, Rupinder, Ang, Joo Chew, Asad, Yasmin J, Henley, Alan T, Valenti, Melanie, Box, Gary, de, Haven Brandon Alexis, Baird, Richard, Friedman, Lori, Derynck, Mika, Vanhaesebroeck, Bart, Eccles, Suzanne A, Kaye, Stan B, Workman, Paul, de, Bono Johann S, Raynaud, Florence I
Outros Autores:	Antwerp X-ray Analysis, Electrochemistry and Speciation (AXES)
Idioma:	inglês
Publicado em:	American Association for Cancer Research 2019
Acesso em linha:	https://demo7.dspace.org/handle/123456789/449
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!